A detailed history of Omers Administration Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Omers Administration Corp holds 50,865 shares of BSX stock, worth $4.59 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
50,865
Previous 83,665 39.2%
Holding current value
$4.59 Million
Previous $6.44 Million 33.85%
% of portfolio
0.04%
Previous 0.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $2.39 Million - $2.76 Million
-32,800 Reduced 39.2%
50,865 $4.26 Million
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $5.63 Million - $6.5 Million
83,665 New
83,665 $6.44 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $59.6 Million - $178 Million
1,624,700 Added 65.34%
4,111,160 $159 Million
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $35.3 Million - $47.1 Million
-1,000,700 Reduced 28.7%
2,486,460 $92.7 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $31.4 Million - $37 Million
824,549 Added 30.97%
3,487,160 $148 Million
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $667,926 - $743,256
16,200 Added 0.61%
2,662,611 $116 Million
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $1.39 Million - $1.6 Million
36,134 Added 1.38%
2,646,411 $113 Million
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $17.6 Million - $19.8 Million
-498,362 Reduced 16.03%
2,610,277 $101 Million
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $45.4 Million - $57.5 Million
1,369,774 Added 78.77%
3,108,639 $112 Million
Q3 2020

Nov 12, 2020

BUY
$34.44 - $42.23 $3.38 Million - $4.15 Million
98,251 Added 5.99%
1,738,865 $66.4 Million
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $49.5 Million - $64.2 Million
1,640,614 New
1,640,614 $57.6 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.